Cedus Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Cedus General Information

Description

Developer of a medical research platform designed to focus on the healthy development of animals and humans. The company's platform provides research, development, and commercialization of hormone-based healthcare strategies for both the human and companion animal markets, enabling doctors to treat various genetic diseases.

Contact Information

Formerly Known As
Gonex
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Animal Reproduction and BioTechnology Lab
  • Colorado State University
  • Fort Collins, CO 80523
  • United States
+1 (970)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Animal Reproduction and BioTechnology Lab
  • Colorado State University
  • Fort Collins, CO 80523
  • United States
+1 (970)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cedus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 17-Oct-2023 Completed Out of Business
3. Early Stage VC Completed Clinical Trials - General
2. Grant $100K $12K Completed Clinical Trials - General
1. Accelerator/Incubator 14-Sep-2006 $12K $12K Completed Clinical Trials - General
To view Cedus’s complete valuation and funding history, request access »

Cedus Patents

Cedus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2009270920-A1 Recombinant pokeweed antiviral proteins, compositions and methods related thereto Inactive 15-Jul-2008
CA-2730933-A1 Recombinant pokeweed antiviral proteins, compositions and methods related thereto Inactive 15-Jul-2008
EP-2318431-A2 Recombinant pokeweed antiviral proteins, compositions and methods related thereto Active 15-Jul-2008
EP-2318431-B1 Recombinant pokeweed antiviral proteins, compositions and methods related thereto Inactive 15-Jul-2008
US-20110281299-A1 Recombinant pokeweed antiviral proteins, compositions and methods related thereto Active 15-Jul-2008 C07K14/415
To view Cedus’s complete patent history, request access »

Cedus FAQs

  • When was Cedus founded?

    Cedus was founded in 1994.

  • Where is Cedus headquartered?

    Cedus is headquartered in Fort Collins, CO.

  • What industry is Cedus in?

    Cedus’s primary industry is Drug Discovery.

  • Is Cedus a private or public company?

    Cedus is a Private company.

  • What is Cedus’s current revenue?

    The current revenue for Cedus is .

  • How much funding has Cedus raised over time?

    Cedus has raised $12K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process